Bristol-Myers Squibb (BMY) management last Friday called a meeting with Wall Street analysts in what one described as a “semi-urgent…More
When a new safety issue arises with a medicine, regulators typically publicize advisories so that not just physicians, but also…More
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you…More
Now that Marathon Pharmaceuticals has sold its Duchenne muscular dystrophy drug, the company unceremoniously withdrew from a big industry trade…More
WASHINGTON — The beleaguered pharmaceutical industry’s top lobbying group spent about $8 million to influence the federal government during the…More
Adance with the devil. That’s how 33-year-old Elizabeth Mooney describes her struggle with drug addiction, recalling the “little voice” that…More
RESEARCH TRIANGLE PARK, N.C. — North Carolina’s standard license plate bears the motto “First in Flight” — a nod to…More
John Flannery, CEO of GE Healthcare, has worked for General Electric for 30 years, but moved into health care only…More
ATLANTA — Faced with an urgent need to recruit more patients of color into clinical trials, researchers are trying a…More
American taxpayers pour money into basic biomedical research, supporting the development of drugs that pharmaceutical companies sell back to those…More
